Australia markets closed

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.84+0.05 (+0.57%)
At close: 04:00PM EDT
8.88 +0.04 (+0.45%)
After hours: 07:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6688
Avg. Estimate-0.42-0.42-1.72-1.86
Low estimate-0.46-0.46-2.1-3.5
High estimate-0.39-0.38-1.49-1.12
Year ago EPS-0.34-0.38-1.58-1.72
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6677
Avg. Estimate12.65M13.17M56.16M88.43M
Low estimate10M10.9M43M41.89M
High estimate20.8M20.8M83.3M254.9M
Year ago sales12.13M11.02M44.58M56.16M
Sales growth (year/est)4.30%19.50%26.00%57.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.35-0.37-0.38-0.45
Actual EPS-0.34-0.38-0.43-0.42
Difference0.01-0.01-0.050.03
Surprise %2.90%-2.70%-13.20%6.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.42-0.42-1.72-1.86
7 days ago-0.42-0.42-1.72-1.86
30 days ago-0.42-0.42-1.72-1.86
60 days ago-0.43-0.43-1.83-1.65
90 days ago-0.43-0.43-1.85-1.86
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRXRXIndustrySector(s)S&P 500
Current qtr.-23.50%N/AN/AN/A
Next qtr.-10.50%N/AN/AN/A
Current year-8.90%N/AN/AN/A
Next year-8.10%N/AN/AN/A
Next 5 years (per annum)12.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A